{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Completed",
      "city": "New York",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA018916"
        ],
        "brand_name": [
          "HEPARIN SODIUM"
        ],
        "generic_name": [
          "HEPARIN SODIUM"
        ],
        "manufacturer_name": [
          "Hospira, Inc."
        ],
        "product_ndc": [
          "0409-1005",
          "0409-7620",
          "0409-2222"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "HEPARIN SODIUM"
        ],
        "rxcui": [
          "1658690",
          "1658691",
          "1658692"
        ],
        "spl_id": [
          "ecaae7d2-a76e-4eca-b045-6c88d7c2ab8f"
        ],
        "spl_set_id": [
          "32e34077-aff1-4ec7-f9b0-b8e240768fb8"
        ],
        "package_ndc": [
          "0409-7620-13",
          "0409-7620-03",
          "0409-7620-49",
          "0409-7620-59",
          "0409-1005-01",
          "0409-1005-20",
          "0409-2222-01",
          "0409-2222-12"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "ZZ45AB24CA"
        ]
      },
      "product_type": "Drugs",
      "event_id": "91379",
      "recalling_firm": "Pfizer Inc.",
      "address_1": "235 East 42nd Street",
      "address_2": "N/A",
      "postal_code": "10017-5703",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA.",
      "recall_number": "D-0097-2023",
      "product_description": "Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mL bags, a) Case (NDC 0409-7620-59), b) Single Unit (NDC 0409-7620-49), Rx only, Distributed By Hospira, Inc., Lake Forest, IL 60045 USA,",
      "product_quantity": "62,088 bags",
      "reason_for_recall": "Lack of assurance of sterility: Bags have the potential to leak.",
      "recall_initiation_date": "20221229",
      "center_classification_date": "20230105",
      "report_date": "20230111",
      "code_info": "Lot: 5935283, Exp. 12/01/2023"
    }
  ]
}